Astera Labs doubles Q2 revenue to $392M as Chair adopts 10b5-1 plan to sell 1.4M shares

summarizeSummary

Astera Labs reported Q2 revenue of $392.4M, up 104% YoY, with net income of $153.1M. The Chair of the Board adopted a 10b5-1 plan to sell up to 1.4M shares, adding to a pattern of heavy insider selling.

check_boxKey Events · Earnings and Guidance · ALAB

• Revenue More Than Doubles

  Driven by higher unit shipments of Aries, Scorpio, and Taurus products, Q2 2026 revenue hit $392.4 million, a 104% increase from $191.9 million a year ago.

• Net Income Nearly Triples

  Net income surged 199% to $153.1 million, or $0.83 per diluted share, compared to $51.2 million a year ago.

• Gross Margin Compresses

  Gross margin fell 250 basis points to 73.3%, pressured by a shift toward lower-margin hardware modules and $10.2 million in warrant contra-revenue.

• Chair Adopts 10b5-1 Selling Plan

  Manuel Alba, Chair of the Board, adopted a Rule 10b5-1 trading plan on May 22, 2026 to sell up to 1,412,000 shares through August 31, 2027.

auto_awesomeAnalysis · ALAB · Manufacturing

Another blowout quarter for Astera Labs saw revenue more than double year-over-year to $392.4 million, fueled by surging demand for its AI infrastructure connectivity products. Net income nearly tripled to $153.1 million. Gross margin, however, slipped 250 basis points as the product mix shifted toward lower-margin hardware modules and customer warrant costs weighed. The balance sheet remains fortress-like with $1.3 billion in cash and marketable securities. On the governance front, the Chair of the Board adopted a pre-arranged trading plan to sell up to 1.4 million shares — a notable overhang given the recent wave of insider selling that has already seen over $444 million in stock sold by insiders in the past 90 days. The company also disclosed a new customer warrant for 3.26 million shares, which will reduce reported revenue as it vests, and completed two acquisitions to bolster its technology portfolio.